Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Ginekologia Polska
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 94, No 12 (2023)
Guidelines / Expert consensus
Published online: 2023-11-27
View PDF Download PDF file View HTML
Get Citation

Guidelines of the Polish Society of Gynecologists and Obstetricians on the obstetric care of women with obesity

Dorota Bomba-Opon12, Pawel Gutaj2, Malgorzata Kedzia2, Bozena Leszczynska-Gorzelak3, Agata Majewska4, Sandra Radzicka-Mularczyk2, Pawel Stanirowski5, Ewa Wender-Ozegowska2
DOI: 10.5603/gpl.97361
·
Pubmed: 38099668
·
Ginekol Pol 2023;94(12):1011-1029.
Affiliations
  1. Collegium Medicum Jan Kochanowski University of Kielce, Poland
  2. Department of Reproduction, Chair of Perinatal Medicine, Poznan University of Medical Sciences, Poland
  3. Department of Obstetrics and Perinatology, Medical University of Lublin, Poland
  4. Department of Obstetrics and Gynecology, Institute of Mother and Child, Warsaw, Poland
  5. 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland

open access

Vol 94, No 12 (2023)
RECOMMENDATIONS
Published online: 2023-11-27

Abstract

Not available

Abstract

Not available

Full Text:

View PDF Download PDF file View HTML
Get Citation
About this article
Title

Guidelines of the Polish Society of Gynecologists and Obstetricians on the obstetric care of women with obesity

Journal

Ginekologia Polska

Issue

Vol 94, No 12 (2023)

Article type

Guidelines / Expert consensus

Pages

1011-1029

Published online

2023-11-27

Page views

1098

Article views/downloads

1797

DOI

10.5603/gpl.97361

Pubmed

38099668

Bibliographic record

Ginekol Pol 2023;94(12):1011-1029.

Authors

Dorota Bomba-Opon
Pawel Gutaj
Malgorzata Kedzia
Bozena Leszczynska-Gorzelak
Agata Majewska
Sandra Radzicka-Mularczyk
Pawel Stanirowski
Ewa Wender-Ozegowska

References (144)
  1. WHO. Obesity and overweight 2020. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
  2. WorldObesity. Prevalance of Obesity 2022. https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity.
  3. GUS. Odsetek osób w wieku powyżej 15 lat według indeksu masy ciała (BMI). Wyniki opracowane przez GUS na podstawie Europejskiego Ankietowego Badania Zdrowia (European Health Interview Survey – EHIS) 2019.
  4. Guelinckx I, Devlieger R, Beckers K, et al. Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev. 2008; 9(2): 140–150.
    CrossRefPubMed
  5. Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynecol. 2008; 1(4): 170–178.
    PubMed
  6. Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG. 2006; 113(10): 1126–1133.
  7. Scott-Pillai R, Spence D, Cardwell CR, et al. The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011. BJOG. 2013; 120(8): 932–939.
    CrossRefPubMed
  8. O'Reilly JR, Reynolds RM. The risk of maternal obesity to the long-term health of the offspring. Clin Endocrinol (Oxf). 2013; 78(1): 9–16.
    CrossRefPubMed
  9. Chen YH, Kang JH, Lin CC, et al. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol. 2012; 206(2): 136.e1–136.e5.
    CrossRefPubMed
  10. Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001; 25(8): 1175–1182.
    CrossRefPubMed
  11. Amir LH, Donath S. A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy Childbirth. 2007; 7: 9.
    CrossRefPubMed
  12. Hollis J, Robinson S. A Link Between Maternal and Childhood Obesity. Global Perspectives on Childhood Obesity. 2019: 125–136.
    CrossRef
  13. Cha E, Smart MJ, Braxter BJ, et al. Preconception Care to Reduce the Risks of Overweight and Obesity in Women of Reproductive Age: An Integrative Review. Int J Environ Res Public Health. 2021; 18(9).
    CrossRefPubMed
  14. Hieronimus B, Ensenauer R. Influence of maternal and paternal pre-conception overweight/obesity on offspring outcomes and strategies for prevention. Eur J Clin Nutr. 2021; 75(12): 1735–1744.
    CrossRefPubMed
  15. Taghavi SA, van Wely M, Jahanfar S, et al. Pharmacological and non-pharmacological strategies for obese women with subfertility. Cochrane Database Syst Rev. 2021; 3(3): CD012650.
    CrossRefPubMed
  16. Kim SY, Park ES, Kim HW. Effectiveness of Non-Pharmacological Interventions for Overweight or Obese Infertile Women: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020; 17(20).
    CrossRefPubMed
  17. Oussaada SM, van Galen KA, Cooiman MI, et al. The pathogenesis of obesity. Metabolism. 2019; 92: 26–36.
    CrossRefPubMed
  18. Most J, Rebello CJ, Altazan AD, et al. Behavioral Determinants of Objectively Assessed Diet Quality in Obese Pregnancy. Nutrients. 2019; 11(7).
    CrossRefPubMed
  19. Gill L, Mackey S. Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists. J Womens Health (Larchmt). 2021; 30(7): 1016–1027.
    CrossRefPubMed
  20. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab. 2020; 105(8): e2695–e2709.
    CrossRefPubMed
  21. Shawe J, Ceulemans D, Akhter Z, et al. Pregnancy after bariatric surgery: Consensus recommendations for periconception, antenatal and postnatal care. Obes Rev. 2019; 20(11): 1507–1522.
    CrossRefPubMed
  22. Ribeiro LM, Sasaki LMP, Silva AA, et al. Overweight, obesity and assisted reproduction: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022; 271: 117–127.
    CrossRefPubMed
  23. Palomba S, Falbo A, Zullo F, et al. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009; 30(1): 1–50.
    CrossRefPubMed
  24. Formoso G, Baldassarre MPA, Ginestra F, et al. Inositol and antioxidant supplementation: Safety and efficacy in pregnancy. Diabetes Metab Res Rev. 2019; 35(5): e3154.
    CrossRefPubMed
  25. Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015; 3(10): 778–786.
    CrossRefPubMed
  26. van der Windt M, Schoenmakers S, van Rijn B, et al. Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy. Nutrients. 2021; 13(2).
    CrossRefPubMed
  27. Maffoni S, De Giuseppe R, Stanford FC, et al. Folate status in women of childbearing age with obesity: a review. Nutr Res Rev. 2017; 30(2): 265–271.
    CrossRefPubMed
  28. Dwyer ER, Filion KB, MacFarlane AJ, et al. Who should consume high-dose folic acid supplements before and during early pregnancy for the prevention of neural tube defects? BMJ. 2022; 377: e067728.
    CrossRefPubMed
  29. Bomba-Opoń D, Hirnle L, Kalinka J, et al. Suplementacja folianów w okresie przedkoncepcyjnym, w ciąży i połogu. Rekomendacje Polskiego Towarzystwa Ginekologów i Położników. Ginekologia i Perinatologia Praktyczna. 2017; 2(5): 210–214.
  30. Wilson RD, O'Connor DL. Guideline No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid-Sensitive Congenital Anomalies. J Obstet Gynaecol Can. 2022; 44(6): 707–719.e1.
    CrossRefPubMed
  31. Cavalli P, Ronda E. Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy. Int J Endocrinol. 2017; 2017: 5846286.
    CrossRefPubMed
  32. Siega-Riz AM, Viswanathan M, Moos MK, et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol. 2009; 201(4): 339.e1–339.14.
    CrossRefPubMed
  33. Beyerlein A, Lack N, von Kries R. Within-population average ranges compared with Institute of Medicine recommendations for gestational weight gain. Obstet Gynecol. 2010; 116(5): 1111–1118.
    CrossRefPubMed
  34. Beyerlein A, Schiessl B, Lack N, et al. Associations of gestational weight loss with birth-related outcome: a retrospective cohort study. BJOG. 2011; 118(1): 55–61.
    CrossRefPubMed
  35. Koletzko B, Bauer CP, Bung P, et al. German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'. Ann Nutr Metab. 2013; 63(4): 311–322.
    CrossRefPubMed
  36. WHO Guidelines on Physical Activity and Sedentary Behaviour 2020.
  37. Berghella V, Saccone G. Exercise in pregnancy! Am J Obstet Gynecol. 2017; 216(4): 335–337.
    CrossRefPubMed
  38. Hincz P, Borowski D, Krekora M, et al. Maternal obesity as a perinatal risk factor. Ginekol Pol. 2009; 80(5): 334–337.
    PubMed
  39. Horvath K, Koch K, Jeitler K, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ. 2010; 340: c1395.
    CrossRefPubMed
  40. American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022; 45(Suppl 1): S232–S243.
    CrossRefPubMed
  41. Doi SAR, Furuya-Kanamori L, Toft E, et al. Metformin in pregnancy to avert gestational diabetes in women at high risk: Meta-analysis of randomized controlled trials. Obes Rev. 2020; 21(1): e12964.
    CrossRefPubMed
  42. Wender-Ożegowska E, Bomba-Opoń D, Brązert J, et al. Standardy Polskiego Towarzystwa Ginekologów i Położników postępowania u kobiet z cukrzycą. Ginekologia i Perinatologia Praktyczna. 2017; 2(5): 215–229.
  43. Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, et al. 2022 Guidelines on the management of patients with diabetes. A position of Diabetes Poland. Current Topics in Diabetes. 2022; 2(1): 1–130.
    CrossRef
  44. Borowski D, Pietryga M, Basta P, et al. Practice guidelines of the Polish Society of Gynecologists and Obstetricians - Ultrasound Section for ultrasound screening in uncomplicated pregnancy - 2020. Ginekol Pol. 2020; 91(8): 490–501.
    CrossRefPubMed
  45. Sieroszewski P, Haus O, Zimmer M, et al. Recommendations for prenatal diagnostics of the Polish Society of Gynaecologists and Obstetricians and the Polish Society of Human Genetics. Ginekol Pol. 2022; 93(5): 427–437.
    CrossRefPubMed
  46. Sieroszewski P, Wielgos M, Radowicki S, et al. Cell-free fetal DNA testing in prenatal diagnosis: Recommendations of the Polish Gynecological Society and the Polish Human Genetics Society. Eur J Obstet Gynecol Reprod Biol. 2017; 214: 190–191.
    CrossRefPubMed
  47. Paladini D. Sonography in obese and overweight pregnant women: clinical, medicolegal and technical issues. Ultrasound Obstet Gynecol. 2009; 33(6): 720–729.
    CrossRefPubMed
  48. Thornburg LL, Mulconry M, Post A, et al. Fetal nuchal translucency thickness evaluation in the overweight and obese gravida. Ultrasound Obstet Gynecol. 2009; 33(6): 665–669.
    CrossRefPubMed
  49. Gandhi M, Fox NS, Russo-Stieglitz K, et al. Effect of increased body mass index on first-trimester ultrasound examination for aneuploidy risk assessment. Obstet Gynecol. 2009; 114(4): 856–859.
    CrossRefPubMed
  50. Aagaard-Tillery KM, Flint Porter T, Malone FD, et al. Influence of maternal BMI on genetic sonography in the FaSTER trial. Prenat Diagn. 2010; 30(1): 14–22.
    CrossRefPubMed
  51. Hildebrand E, Källén B, Josefsson A, et al. Maternal obesity and risk of Down syndrome in the offspring. Prenat Diagn. 2014; 34(4): 310–315.
    CrossRefPubMed
  52. Ashoor G, Syngelaki A, Poon LCY, et al. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2013; 41(1): 26–32.
    CrossRefPubMed
  53. Rolnik DL, Yong Y, Lee TJ, et al. Influence of Body Mass Index on Fetal Fraction Increase With Gestation and Cell-Free DNA Test Failure. Obstet Gynecol. 2018; 132(2): 436–443.
    CrossRefPubMed
  54. Wang E, Batey A, Struble C, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. 2013; 33(7): 662–666.
    CrossRefPubMed
  55. Harper LM, Cahill AG, Smith K, et al. Effect of maternal obesity on the risk of fetal loss after amniocentesis and chorionic villus sampling. Obstet Gynecol. 2012; 119(4): 745–751.
    CrossRefPubMed
  56. Stothard KJ, Tennant PWG, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009; 301(6): 636–650.
    CrossRefPubMed
  57. Waller DK, Shaw GM, Rasmussen SA, et al. National Birth Defects Prevention Study. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007; 161(8): 745–750.
    CrossRefPubMed
  58. Dashe JS, McIntire DD, Twickler DM. Effect of maternal obesity on the ultrasound detection of anomalous fetuses. Obstet Gynecol. 2009; 113(5): 1001–1007.
    CrossRefPubMed
  59. Dashe JS, McIntire DD, Twickler DM. Maternal obesity limits the ultrasound evaluation of fetal anatomy. J Ultrasound Med. 2009; 28(8): 1025–1030.
    CrossRefPubMed
  60. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004; 191(3): 964–968.
    CrossRefPubMed
  61. Johansson K, Cnattingius S, Näslund I, et al. Outcomes of pregnancy after bariatric surgery. N Engl J Med. 2015; 372(9): 814–824.
    CrossRefPubMed
  62. Neel A, Cunningham CE, Teale GR. A routine third trimester growth ultrasound in the obese pregnant woman does not reliably identify fetal growth abnormalities: A retrospective cohort study. Aust N Z J Obstet Gynaecol. 2021; 61(1): 116–122.
    CrossRefPubMed
  63. Harper LM, Jauk VC, Owen J, et al. The utility of ultrasound surveillance of fluid and growth in obese women. Am J Obstet Gynecol. 2014; 211(5): 524.e1–524.e8.
    CrossRefPubMed
  64. Sakowicz A, Grobman WA, Miller ES. The Diagnostic Utility of Growth Ultrasound for the Indication of Maternal Overweight or Obesity. Am J Perinatol. 2022 [Epub ahead of print].
    CrossRefPubMed
  65. Lavie CJ, Arena R, Alpert MA, et al. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018; 15(1): 45–56.
    CrossRefPubMed
  66. Buddeberg BS, Sharma R, O'Driscoll JM, et al. Cardiac maladaptation in obese pregnant women at term. Ultrasound Obstet Gynecol. 2019; 54(3): 344–349.
    CrossRefPubMed
  67. Bicocca MJ, Mendez-Figueroa H, Chauhan SP, et al. Maternal Obesity and the Risk of Early-Onset and Late-Onset Hypertensive Disorders of Pregnancy. Obstet Gynecol. 2020; 136(1): 118–127.
    CrossRefPubMed
  68. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003; 14(3): 368–374.
    CrossRefPubMed
  69. Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018; 218(6): 573–580.
    CrossRefPubMed
  70. Bedell S, Hutson J, de Vrijer B, et al. Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions. Curr Vasc Pharmacol. 2021; 19(2): 176–192.
    CrossRefPubMed
  71. Lockwood CJ, Huang SJ, Chen CP, et al. Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia. Am J Pathol. 2013; 183(3): 841–856.
    CrossRefPubMed
  72. Prejbisz A, Dobrowolski P, Kosiński P, et al. Postępowanie w nadciśnieniu tętniczym u kobiet w ciąży. Zapobieganie, diagnostyka, leczenie i odległe rokowanie. Stanowisko Polskiego Towarzystwa Nadciśnienia Tętniczego, Polskiego Towarzystwa Kardiologicznego oraz Polskiego Towarzystwa Ginekologów i Położników. Ginekologia i Perinatologia Praktyczna. 2019; 4(2): 43–111.
  73. Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018; 218(3): 287–293.e1.
    CrossRefPubMed
  74. Bujold E, Roberge S, Nicolaides KH. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn. 2014; 34(7): 642–648.
    CrossRefPubMed
  75. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017; 377(7): 613–622.
    CrossRefPubMed
  76. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008; 6(6): 905–912.
    CrossRefPubMed
  77. PTG. Low-weight heparin treatment in obstetrics and gynecology – the Polish Gynecological Society. Ginekol Pol. 2010; 81(4).
  78. Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol. 2011; 118(3): 561–568.
    CrossRefPubMed
  79. Vahratian A, Zhang J, Troendle JF, et al. Maternal prepregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstet Gynecol. 2004; 104(5 Pt 1): 943–951.
    CrossRefPubMed
  80. Carlhäll S, Källén K, Thorsell A, et al. Maternal body mass index and duration of labor. Eur J Obstet Gynecol Reprod Biol. 2013; 171(1): 49–53.
    CrossRefPubMed
  81. Zhang J, Bricker L, Wray S, et al. Poor uterine contractility in obese women. BJOG. 2007; 114(3): 343–348.
    CrossRefPubMed
  82. Higgins CA, Martin W, Anderson L, et al. Maternal obesity and its relationship with spontaneous and oxytocin-induced contractility of human myometrium in vitro. Reprod Sci. 2010; 17(2): 177–185.
    CrossRefPubMed
  83. Lauterbach R, Ben Zvi D, Dabaja H, et al. Vaginal Dinoprostone Insert versus Cervical Ripening Balloon for Term Induction of Labor in Obese Nulliparas-A Randomized Controlled Trial. J Clin Med. 2022; 11(8).
    CrossRefPubMed
  84. Beckwith L, Magner K, Kritzer S, et al. Prostaglandin versus mechanical dilation and the effect of maternal obesity on failure to achieve active labor: a cohort study. J Matern Fetal Neonatal Med. 2017; 30(13): 1621–1626.
    CrossRefPubMed
  85. Ashraf R, Maxwell C, D'Souza R. Induction of labour in pregnant individuals with obesity. Best Pract Res Clin Obstet Gynaecol. 2022; 79: 70–80.
    CrossRefPubMed
  86. Lee VR, Darney BG, Snowden JM, et al. Term elective induction of labour and perinatal outcomes in obese women: retrospective cohort study. BJOG. 2016; 123(2): 271–278.
    CrossRefPubMed
  87. Eberle A, Czuzoj-Shulman N, Azoulay L, et al. Induction of labor at 39 weeks and risk of cesarean delivery among obese women: a retrospective propensity score matched study. J Perinat Med. 2021; 49(7): 791–796.
    CrossRefPubMed
  88. Boulvain M, Irion O, Thornton J. Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database of Systematic Reviews. 2016; 2022(8).
    CrossRef
  89. Subramaniam A, Jauk VC, Goss AR, et al. Mode of delivery in women with class III obesity: planned cesarean compared with induction of labor. Am J Obstet Gynecol. 2014; 211(6): 700.e1–700.e9.
    CrossRefPubMed
  90. Hibbard JU, Gilbert S, Landon MB, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol. 2006; 108(1): 125–133.
    CrossRefPubMed
  91. Naumann RW, Hauth JC, Owen J, et al. Subcutaneous tissue approximation in relation to wound disruption after cesarean delivery in obese women. Obstet Gynecol. 1995; 85(3): 412–416.
    CrossRefPubMed
  92. Bratzler D, Dellinger E, Olsen K, et al. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery. Surgical Infections. 2013; 14(1): 73–156.
    CrossRef
  93. McLean M, Hines R, Polinkovsky M, et al. Type of skin incision and wound complications in the obese parturient. Am J Perinatol. 2012; 29(4): 301–306.
    CrossRefPubMed
  94. Scolari Childress KM, Gavard JA, Ward DG, et al. A barrier retractor to reduce surgical site infections and wound disruptions in obese patients undergoing cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol. 2016; 214(2): 285.e1–285.e10.
    CrossRefPubMed
  95. Durnwald CP, Ehrenberg HM, Mercer BM. The impact of maternal obesity and weight gain on vaginal birth after cesarean section success. Am J Obstet Gynecol. 2004; 191(3): 954–957.
    CrossRefPubMed
  96. Taylor CR, Dominguez JE, Habib AS. Obesity And Obstetric Anesthesia: Current Insights. Local Reg Anesth. 2019; 12: 111–124.
    CrossRefPubMed
  97. Mhyre JM, Riesner MN, Polley LS, et al. A series of anesthesia-related maternal deaths in Michigan, 1985-2003. Anesthesiology. 2007; 106(6): 1096–1104.
    CrossRefPubMed
  98. Mushambi MC, Kinsella SM, Popat M, et al. Obstetric Anaesthetists' Association, Difficult Airway Society. Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia. 2015; 70(11): 1286–1306.
    CrossRefPubMed
  99. Robinson HE, O'Connell CM, Joseph KS, et al. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol. 2005; 106(6): 1357–1364.
    CrossRefPubMed
  100. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol. 2002; 100(5 Pt 1): 959–964.
    CrossRefPubMed
  101. Mourad M, Silverstein M, Bender S, et al. The effect of maternal obesity on outcomes in patients undergoing tertiary or higher cesarean delivery. J Matern Fetal Neonatal Med. 2015; 28(9): 989–993.
    CrossRefPubMed
  102. Smid MC, Kearney MS, Stamilio DM. Extreme Obesity and Postcesarean Wound Complications in the Maternal-Fetal Medicine Unit Cesarean Registry. Am J Perinatol. 2015; 32(14): 1336–1341.
    CrossRefPubMed
  103. Smid MC, Dotters-Katz SK, Silver RM, et al. Body Mass Index 50 kg/m2 and Beyond: Perioperative Care of Pregnant Women With Superobesity Undergoing Cesarean Delivery. Obstet Gynecol Surv. 2017; 72(8): 500–510.
    CrossRefPubMed
  104. National Blood Authority Australia. Expert panel consensus position statement regarding the use of Rh(D) immunoglobulin in patients with a body mass index > 30. 2020.
  105. Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008; 6(4): 632–637.
    CrossRefPubMed
  106. Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e691S–e736S.
    CrossRefPubMed
  107. Kevane B, Donnelly J, D'Alton M, et al. Risk factors for pregnancy-associated venous thromboembolism: a review. J Perinat Med. 2014; 42(4): 417–425.
    CrossRefPubMed
  108. Blondon M, Harrington LB, Boehlen F, et al. Pre-pregnancy BMI, delivery BMI, gestational weight gain and the risk of postpartum venous thrombosis. Thromb Res. 2016; 145: 151–156.
    CrossRefPubMed
  109. CMACE/RCOG Joint Guideline. Management of Women with Obesity in Pregnancy 2010.
  110. Maxwell C, Gaudet L, Cassir G, et al. Guideline No. 392-Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care. J Obstet Gynaecol Can. 2019; 41(11): 1660–1675.
    CrossRefPubMed
  111. Overcash RT, Somers AT, LaCoursiere DY. Enoxaparin dosing after cesarean delivery in morbidly obese women. Obstet Gynecol. 2015; 125(6): 1371–1376.
    CrossRefPubMed
  112. Sagi-Dain L. Obesity in Pregnancy: ACOG Practice Bulletin Summary, Number 230. Obstet Gynecol. 2021; 137(6): 1137–1139.
    CrossRefPubMed
  113. Lepe M, Bacardí Gascón M, Castañeda-González LM, et al. Effect of maternal obesity on lactation: systematic review. Nutr Hosp. 2011; 26(6): 1266–1269.
    CrossRefPubMed
  114. Visram H, Finkelstein SA, Feig D, et al. Breastfeeding intention and early post-partum practices among overweight and obese women in Ontario: a selective population-based cohort study. J Matern Fetal Neonatal Med. 2013; 26(6): 611–615.
    CrossRefPubMed
  115. Baker JL, Michaelsen KF, Sørensen TIA, et al. High prepregnant body mass index is associated with early termination of full and any breastfeeding in Danish women. Am J Clin Nutr. 2007; 86(2): 404–411.
    CrossRefPubMed
  116. Garner CD, McKenzie SA, Devine CM, et al. Obese women experience multiple challenges with breastfeeding that are either unique or exacerbated by their obesity: discoveries from a longitudinal, qualitative study. Matern Child Nutr. 2017; 13(3).
    CrossRefPubMed
  117. Lyons S, Currie S, Smith DM. Learning from Women with a Body Mass Index (Bmi) ≥ 30 kg/m who have Breastfed and/or are Breastfeeding: a Qualitative Interview Study. Matern Child Health J. 2019; 23(5): 648–656.
    CrossRefPubMed
  118. Rasmussen KM, Kjolhede CL. Prepregnant overweight and obesity diminish the prolactin response to suckling in the first week postpartum. Pediatrics. 2004; 113(5): e465–e471.
    CrossRefPubMed
  119. Torloni MR, Betrán AP, Horta BL, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009; 10(2): 194–203.
    CrossRefPubMed
  120. Lisonkova S, Muraca GM, Potts J, et al. Association Between Prepregnancy Body Mass Index and Severe Maternal Morbidity. JAMA. 2017; 318(18): 1777–1786.
    CrossRefPubMed
  121. Schummers L, Hutcheon JA, Bodnar LM, et al. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol. 2015; 125(1): 133–143.
    CrossRefPubMed
  122. Molyneaux E, Poston L, Ashurst-Williams S, et al. Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis. Obstet Gynecol. 2014; 123(4): 857–867.
    CrossRefPubMed
  123. Rozporządzenie Ministra Zdrowia z dnia 16 sierpnia 2018 r. w sprawie standardu organizacyjnego opieki okołoporodowej – Dz U. z 2018 poz. 1756).
  124. Bodnar LM, Siega-Riz AM, Cogswell ME. High prepregnancy BMI increases the risk of postpartum anemia. Obes Res. 2004; 12(6): 941–948.
    CrossRefPubMed
  125. McBain RD, Dekker GA, Clifton VL, et al. Impact of inter-pregnancy BMI change on perinatal outcomes: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2016; 205: 98–104.
    CrossRefPubMed
  126. Whiteman VE, Crisan L, McIntosh C, et al. Interpregnancy body mass index changes and risk of stillbirth. Gynecol Obstet Invest. 2011; 72(3): 192–195.
    CrossRefPubMed
  127. Callegari LS, Sterling LA, Zelek ST, et al. Interpregnancy body mass index change and success of term vaginal birth after cesarean delivery. Am J Obstet Gynecol. 2014; 210(4): 330.e1–330.e7.
    CrossRefPubMed
  128. Jain AP, Gavard JA, Rice JJ, et al. The impact of interpregnancy weight change on birthweight in obese women. Am J Obstet Gynecol. 2013; 208(3): 205.e1–205.e7.
    CrossRefPubMed
  129. National Institute for Health and Care Excellence. Pressure ulcers: prevention and management. clinical guideline 179. 2014.
  130. National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. NICE Guideline 3. 2015.
  131. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005; 115(3): e290–e296.
    CrossRefPubMed
  132. Catalano PM, Farrell K, Thomas A, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2009; 90(5): 1303–1313.
    CrossRefPubMed
  133. Philipps LH, Santhakumaran S, Gale C, et al. The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis. Diabetologia. 2011; 54(8): 1957–1966.
    CrossRefPubMed
  134. Patel SP, Rodriguez A, Little MP, et al. Associations between pre-pregnancy obesity and asthma symptoms in adolescents. J Epidemiol Community Health. 2012; 66(9): 809–814.
    CrossRefPubMed
  135. Thiel de Bocanegra H, Chang R, Howell M, et al. Interpregnancy intervals: impact of postpartum contraceptive effectiveness and coverage. Am J Obstet Gynecol. 2014; 210(4): 311.e1–311.e8.
    CrossRefPubMed
  136. Tepper NK, Curtis KM, Cox S, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016; 65(3): 1–103.
    CrossRefPubMed
  137. Faculty of Sexual & Reproductive Healthcare. Contraception After Pregnancy. . 2017.
  138. Black A, Guilbert E, Costescu D, et al. Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception. J Obstet Gynaecol Can. 2016; 38(3): 279–300.
    CrossRefPubMed
  139. Black A, Guilbert E, Costescu D, et al. No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception. J Obstet Gynaecol Can. 2017; 39(4): 229–268.e5.
    CrossRefPubMed
  140. Westhoff CL, Torgal AH, Mayeda ER, et al. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 2010; 81(6): 474–480.
    CrossRefPubMed
  141. Lotke PS, Kaneshiro B. Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women. Obstet Gynecol Clin North Am. 2015; 42(4): 647–657.
    CrossRefPubMed
  142. Merki-Feld GS, Skouby S, Serfaty D, et al. European society of contraception statement on contraception in obese women. Eur J Contracept Reprod Health Care. 2015; 20(1): 19–28.
    CrossRefPubMed
  143. Lopez LM, Bernholc A, Chen M, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2016; 2016(8): CD008452.
    CrossRefPubMed
  144. Sweetland S, Beral V, Balkwill A, et al. Million Women Study Collaborators. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost. 2012; 10(11): 2277–2286.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl